Gotta love RCTs. High risk PCa with adequate ADT with nodal RT.
Compare those biochemical-failure-free survival outcomes to any high risk trial out there. How do you beat that?
Once published, this is now the new SOC for high risk PCa. Nothing comes close I have seen!
#ASTRO20: Sexual Health Often Overlooked in Female Cancer Survivors - Male respondents were twice as likely to say they were asked and counseled about potential toxicity (53% vs. 22%). James Taylor, MD, MPH, https://t.co/Er2GMgHXGn @KimmelCancerCtr
While time slot overlaps with the superb Presidential Symposium (OnDemand), this Quick Pitch session is LIVE! Come hear these fantastic presenters at 11:30 (T.J. Eichler Theatre -> Science Center) @aiims2738 @gjmcginnis @Surbhigrov@MutlaySayan@dbittermanmd@JamesTaylorMD
It’s that time of year again, and I am pleased and honored to share the work of our trainees and faculty that will be presented at the Annual American Society of Radiation Oncology. https://t.co/q4fmjvSUFE @KimmelCancerCtr@JeffersonUniv@TJUHospital
Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases https://t.co/yGTCss2MfN via @JAMAOnc part of @JAMANetwork. This study took the last 20 minutes of our QA today! @wasik_maria had a lot to say! @DrewMoghanaki @cgr0105